Navigation Links
MIGENIX Corporate Update and Requisition of Special Meeting
Date:7/8/2008

Board and Management Focused on Near-Term Milestones and Maintain

Commitment to Strategy

VANCOUVER and SAN DIEGO, July 8 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, has received a requisition for a special meeting of shareholders for the purpose of acquiring control of MIGENIX's board of directors (see "Requisition of Shareholder Meeting"). Management and the board maintain their commitment to all MIGENIX shareholders to create value based on our existing pharmaceutical product development strategy and are continuing to work diligently on opportunities to create value (see "Program Update").

Jim DeMesa, M.D., President and CEO of MIGENIX stated, "Since announcing our strategic plan in 2002, management has maintained a focus on achieving the objectives outlined in that plan to build long-term value for our shareholders. Familiar to all in the biotech space, drug development is a long, risky process with many setbacks. We have been navigating that course and are now on the verge of some of the results of our strategy. Importantly, we are very close to a pivotal milestone for our latest-stage product candidate - Omigard(TM), with Phase III clinical results expected before the end of the calendar year (see "Program Update" below). Armed with positive results from this study, our partner in this program, Cadence Pharmaceuticals, plans to submit a New Drug Application (NDA) for marketing approval of Omigard(TM) in the United States in the first half of calendar 2009 - which is a significant event for any biotech or pharmaceutical company. Also, with positive Phase III results, we expect to partner the additional commercial rights to Omigard to maximize revenue to the Company for further value creation. This is in addition to the potential US$27MM in milestone payments under our agreement with Cadence and double digit royalty revenue on net sale
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
3. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
4. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
6. MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
7. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
8. MIGENIX releases CEO message #22
9. MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
10. MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results
11. MIGENIX Appoints Pieter Dorsman to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...wswire-FirstCall/ -- Par Pharmaceutical Companies,... District Court for the District of New Jersey las...n for a temporary restraining order (TRO) halting ...esonide inhaled solution). In conjunction with th...nd that it too would halt all sales of its authori...
(Date:11/20/2008)...-FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ), a...remium,diagnostics, medical imaging systems and s...are needs of women, today announced the Company wi...ommunity who will be attending the RSNA,(Radiolog...go. , This meeting will be held on Tuesday,...
(Date:11/20/2008)...ses Seno,s Opto-Acoustic Imaging Technology, T...Cellular Level and Aid, in the Pursuit of Neur... Cancer Applications, , , TORONTO and SA... and Seno Medical Instruments today announced the ...g VisualSonics exclusive rights to Seno Medical,s ...
(Date:11/20/2008)...ire-FirstCall/ -- Varian, Inc.,(NasdaqGS: VARI) t...nd CEO,will speak at the Nasdaq OMX 22nd Investo... at 9:45 a.m. Eastern time. , A live webcas...rom Varian,Inc.,s Web site at http://www.varian...lick on "Investors." An archived replay will be a...
Breaking Biology Technology:Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2Hologic, Inc. to Host Investor Reception at the RSNA Trade Show 2VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research 2VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research 3
...s. -- Network Health Plan , Affinity Health Syste... and HealthTrio announced today the availability...s, employers and brokers through HealthTrio connec...NHP will launch the product suite in two phases, b...g this summer, NHPs providers will be able to exch...
...p is the living legend with one of the greatest su...hat fits like a glove his personality and his busi...l marketer with a great personality and now with t...V shows series, wants to own the term Youre fired....ity of our business protocols is still a sheet of ...
...ntrepreneurs located in Wisconsin will have a shot...cond annual Wisconsin Entrepreneurs Conference, wh...sconsin Innovation Network will hold June 1 and 2...ers recently began to call for nominations for the...e. , ,"Wisconsin needs more innovators who ,seize ...
...eaking to a home-state crowd last week, Health and... how his agency touches Americans in unseen ways e...hey take to administering their Medicare accounts ..., ,We just want you to eat less of it (food), joke...shed 15 pounds in his personal quest to lead a hea...
Other Biology Technology:"You're fired!" Trump wants trademark rights 2New Seize the Day award available to Wisconsin entrepreneurs 2Americas weighty problem: Why the fight against fat is about more than just looking good 2Americas weighty problem: Why the fight against fat is about more than just looking good 3
(Date:11/21/2008)...n Halkier, Department of Plant Biology and Biotech... of Copenhagen, has been granted the Danisco Award...excellent research into secondary metabolites, whi...ance, plants. In particular, her research has foc...sport of glucosinolates in cruciferous plants. ,...
(Date:11/20/2008)...wth from Operations in Third Quarter , , JE...METRX, Inc. (OTC Bulletin Board: BMRX), a leading ...ducts, today announced its financial results for t... Revenues for the third quarter were $431,840, whi...revenues of $100,000. , , -- The Company a...
(Date:11/20/2008)...ical Institute at St. Joseph,s Hospital and Medica... motions and the perception of illusory motion tha...nik, PhD, director of the Laboratory of Behavioral...ctor of the Laboratory of Visual Neuroscience; Xoa...cted a study based on the Enigma painting, a visua...
(Date:11/20/2008)...hates strangers. When its security patrol spots a ...roblem when people with type 1 diabetes undergo hu...om a donor pancreas produce robust amounts of insu...ence from insulin therapy. However, the immune sys... A person who has the transplant procedure must ta...
Breaking Biology News(10 mins):The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen 2bioMETRX, Inc. Highlights 3rd Quarter 2008 Financial Results 2Researcher tricks immune system in diabetic mice 2Luczo Dragon IndyCar Carries Eyes on the Road Logo to Prevent Blindness to Indy 500 19892 1Luczo Dragon IndyCar Carries Eyes on the Road Logo to Prevent Blindness to Indy 500 19892 2Forty Two Free Clinics Across State Share 241 Million in Grants From Blue Cross Blue Shield of Michigan 19889 1Forty Two Free Clinics Across State Share 241 Million in Grants From Blue Cross Blue Shield of Michigan 19889 2Forty Two Free Clinics Across State Share 241 Million in Grants From Blue Cross Blue Shield of Michigan 19889 3Forty Two Free Clinics Across State Share 241 Million in Grants From Blue Cross Blue Shield of Michigan 19889 4Elseviers Engineering Village Search Platform Combines the American Geological Institutes Georef Database With Google Maps 5544 1Elseviers Engineering Village Search Platform Combines the American Geological Institutes Georef Database With Google Maps 5544 2Elseviers Engineering Village Search Platform Combines the American Geological Institutes Georef Database With Google Maps 5544 3Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 1Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 2Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 3Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 4Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 5Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 6Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 7Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 8
...ceptor through which a group of life-threatening h...,s cells, and show that infection can be inhibited...blished online by the journal Nature on February 7...renaviruses, suggest a way of reducing the severit...needed treatment strategy. , The four viruses, kn...
...mmercial farming of salmon in the 1960s, the indus...s expanded to such a degree that prices for farmed...farmed fish may become the next invasive species. ...t become an invasive species in British Columbia, ...t Peter Bisson. "Net pen culture of salmon is big ...
... Journal of the National Cancer Institute quanti...rs developing specific subtypes of soft tissue sar...s after the original retinoblastoma diagnosis. The...cal surveillance for these patients, the authors s...na that primarily affects children and is most oft...
...s responsible for stimulating the appetite make su...reported in the January issue of the journal Cell ...omplex series of molecular events that keep those ... between active thyroid hormone in the brain and i...osts the number of power-generating mitochondria i...
Other Biology News:Discovery could lead to better control of hemorrhagic fever viruses 2Discovery could lead to better control of hemorrhagic fever viruses 3Farmed salmon could become an invasive species in forest streams 2Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors 2How appetite-stimulating brain cells work overtime during fasting 2How appetite-stimulating brain cells work overtime during fasting 3
...lized. Lyophilized from 2 mM sodium phosphate buff...n D is a major lysosomal aspartyl protease in mamm...pression of cathepsin D in human breast cancers is...asis. Cathepsin D degrades extracellular matrix an...
Acetate Plate Sealers 100/Box
Phytohemagglutinin from Invitrogen
Rat Lung Fibroblasts (RLF) (>500,000 cells)
Biology Products: